US Vitamin B5 Market Extends Soft Trend as Comfortable Inventories Weigh on Prices

The US Vitamin B5 market is anticipated to remain under mild pressure through July 2026 as ample global supply, comfortable importer inventories, and cautious downstream procurement continue to outweigh cost-side pressures. This follows a 1.43% month-on-month decline in Vitamin B5 CFR New York prices during June, driven by aggressive exporter pricing, inventory liquidation, and subdued buying across several end-use industries.

Supply and demand dynamics remained broadly imbalanced during June. On the supply side, exporting facilities across eastern China and Western Europe operated without reported outages, ensuring abundant Vitamin B5 availability for the U.S. market. Sellers actively cleared inventories accumulated following spring maintenance shutdowns, increasing cargo availability into New York and intensifying price competition among exporters. At the same time, lower U.S. formaldehyde prices reduced production costs across methanol-linked value chains, allowing suppliers to offer additional discounts despite temporary increases in trans-Pacific freight rates during mid-June.

On the demand side, nutraceutical and dietary supplement manufacturers maintained only moderate purchasing activity amid the seasonal summer slowdown, while pharmaceutical producers relied on existing two-to-three-month inventories and postponed fresh Vitamin B5 imports. Animal nutrition and feed premix manufacturers further reduced spot procurement by drawing down stocks, whereas cosmetic formulators continued routine purchasing without expanding order volumes. The combination of abundant supply and measured demand maintained downward pressure on Vitamin B5 prices throughout the month.

Looking ahead, the Vitamin B5 market is forecast to remain slightly weaker during July as importers continue utilizing existing inventories while exporters maintain competitive pricing to preserve market share. Global production is expected to remain stable, with no major manufacturing disruptions anticipated across leading Asian or European suppliers. Although freight markets remain susceptible to periodic volatility, easing geopolitical tensions around key international shipping routes are expected to support relatively smooth cargo movements. Consequently, Vitamin B5 buyers are likely to retain strong negotiating leverage, limiting the potential for any meaningful price recovery during the early part of the third quarter. Feedstock costs are also expected to remain relatively stable, preventing significant upward pressure on replacement costs and allowing Vitamin B5 suppliers to continue offering competitive export quotations into the U.S. market.

Beyond July, market fundamentals are expected to improve gradually entering August and the beginning of the fourth quarter. Pharmaceutical manufacturers, nutraceutical producers, and dietary supplement companies are anticipated to begin autumn inventory replenishment ahead of stronger seasonal consumption and year-end production schedules. This restocking cycle is likely to improve procurement volumes across the Vitamin B5 market and gradually tighten available inventories. Additionally, logistics disruptions associated with China's Golden Week holiday and higher freight activity during peak shipping season could modestly increase landed import costs. Nevertheless, abundant global manufacturing capacity and healthy export availability are expected to prevent significant supply tightness. Overall, the Vitamin B5 market is projected to transition from its current soft phase toward a more balanced pricing environment during the second half of 2026, although market direction will remain dependent on inventory movements, freight conditions, and seasonal purchasing activity.